好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Superior Clinical Benefits of a New Single-Tablet Formulation of Sumatriptan Formulated with RT Technology[trade] and Naproxen Sodium
Headache and Pain
(-)
001
Authors/Disclosures
Stephen D. Silberstein, MD, FAAN (Jefferson Headache Center) Dr. Silberstein has received publishing royalties from a publication relating to health care.
Stuart R. Stark, MD (FDA) No disclosure on file
Elan Guterman, MD (University of California, San Francisco) Dr. Guterman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Guterman has stock in REMO Health. The institution of Dr. Guterman has received research support from NIH. The institution of Dr. Guterman has received research support from AAN.
Sarah E. DeRossett, MD, PhD (Medpace) No disclosure on file
David C. Taylor, MD No disclosure on file
Susan A. McDonald, MA (GlaxoSmithKline) No disclosure on file
Esther Suarez San Martin, PhD (Sespa) No disclosure on file
Michelle Lener, PharmD (GlaxoSmithKline) No disclosure on file